Immunological Disorders and Immunotherapy

Immunological Disorders and Immunotherapy
Open Access

ISSN: 2593-8509

+44-1904-929220

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aims and Scope

Immunological Disorders and Immunotherapy (IDIT) is a broad-based journal that aims to publish the most exciting and research advancements in Immunology. Secondly, to provide a rapid reviewing and publishing to disseminate articles for research, teaching and reference purposes, free of subscription.

Immunological Disorders and Immunotherapy Journal - Open Access offers barrier-free access to the literature related to chemical engineering for research. It increases convenience, reach, and retrieval power. Free online literature is available in full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Immunological Disorders and Immunotherapy Journal - Open Access eliminates the need for permissions to reproduce and distribute content.

The journal covers all concepts in the fields of  Cell Mediated Immune Disorder, immune system boosters,Tumor Immunology, Immune mechanisms,  Immunodeficiency disorders , Autoimmune disorders ,AIDS, HIV, Congenital disorders, Infectious diseases and  Postnatal disorders

Immunological Disorders and Immunotherapy Journal accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Chemical Engineering field. Journal of Advanced Chemical Engineering strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Advanced Chemical Engineering are freely accessible to everyone immediately after publication.

All works published by Longdom Publishing are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Advanced Chemical Engineering supports the Bethesda Statement on Open Access Publishing.

Definition of Open Access Publication

An Open Access Publication is one that meets the following two conditions:

  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).

As a member of Publisher International linking Association, PILA, Journal of Advanced Chemical Engineering (of Longdom Publishing) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

Top